| Literature DB >> 11796171 |
Luis Felipe Vallejo1, Maren Brokelmann, Sabine Marten, Susanne Trappe, Joaquin Cabrera-Crespo, Andrea Hoffmann, Gerhard Gross, Herbert A Weich, Ursula Rinas.
Abstract
Eschericha coli was genetically engineered to produce recombinant human bone morphogenetic protein-2 (rhBMP-2) in a non-active aggregated form using a temperature-inducible expression system. High concentrations of both biomass (75 g cell dry weight per liter of culture broth) and inactive rhBMP-2 (8.6 gl(-1)) were obtained by applying a high-cell-density cultivation procedure. After washing and solubilizing the inclusion bodies, rhBMP-2 was refolded and dimerized at concentrations up to 100 mgl(-1) by means of a simple dilution method with yields exceeding 50%. Finally, a one-step purification procedure based on affinity chromatography was implemented to isolate the rhBMP-2 dimer. With the established renaturation and purification protocols, yields of more than 10 mg rhBMP-2 dimer per gram cell dry weight were obtained corresponding to 750 mg rhBMP-2 dimer per liter of culture broth. The purified rhBMP-2 dimer showed biological activity equivalent to CHO produced rhBMP-2 as tested by the induction of alkaline phosphatase activity in C2C12 cells.Entities:
Mesh:
Substances:
Year: 2002 PMID: 11796171 DOI: 10.1016/s0168-1656(01)00425-4
Source DB: PubMed Journal: J Biotechnol ISSN: 0168-1656 Impact factor: 3.307